Last checked at 12 Apr 2021 18:02
Ap19
FORM 8.3
Amendment to sales and purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 08 April 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,677,160 | 1.30% | 190,460 | 0.15% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
102,359 | 0.08% | 7,100 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,785,619 | 1.38% | 203,660 | 0.16% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 237.0100 USD |
| Purchase | 2 | 237.1300 USD |
| Purchase | 13 | 237.9700 USD |
| Purchase | 20 | 237.7222 USD |
| Purchase | 80 | 236.9900 USD |
| Purchase | 98 | 237.0200 USD |
| Purchase | 100 | 238.0300 USD |
| Purchase | 167 | 237.1000 USD |
| Purchase | 180 | 237.1587 USD |
| Purchase | 200 | 237.3925 USD |
| Purchase | 368 | 237.8140 USD |
| Purchase | 405 | 237.1540 USD |
| Purchase | 595 | 237.0384 USD |
| Purchase | 709 | 237.9995 USD |
| Purchase | 3,033 | 237.0700 USD |
| Purchase | 3,304 | 237.7637 USD |
| Purchase | 7,934 | 237.1773 USD |
| Purchase | 11,416 | 237.6292 USD |
| Purchase | 52,828 | 237.5919 USD |
| Sale | 2 | 237.2000 USD |
| Sale | 5 | 237.5250 USD |
| Sale | 10 | 237.1000 USD |
| Sale | 10 | 237.2700 USD |
| Sale | 15 | 237.2800 USD |
| Sale | 15 | 237.1616 USD |
| Sale | 45 | 237.2766 USD |
| Sale | 50 | 237.0680 USD |
| Sale | 65 | 237.0300 USD |
| Sale | 90 | 237.6500 USD |
| Sale | 112 | 238.0311 USD |
| Sale | 117 | 237.7554 USD |
| Sale | 170 | 237.1788 USD |
| Sale | 180 | 237.1628 USD |
| Sale | 193 | 237.8090 USD |
| Sale | 200 | 237.9800 USD |
| Sale | 200 | 237.6358 USD |
| Sale | 200 | 239.1231 USD |
| Sale | 201 | 237.7852 USD |
| Sale | 214 | 239.1544 USD |
| Sale | 220 | 237.1950 USD |
| Sale | 268 | 238.0220 USD |
| Sale | 514 | 237.0698 USD |
| Sale | 516 | 238.0707 USD |
| Sale | 830 | 237.4728 USD |
| Sale | 1,066 | 237.5604 USD |
| Sale | 1,116 | 237.2644 USD |
| Sale | 1,422 | 237.9031 USD |
| Sale | 1,536 | 237.6859 USD |
| Sale | 2,600 | 237.5319 USD |
| Sale | 2,776 | 237.7961 USD |
| Sale | 3,547 | 237.0700 USD |
| Sale | 3,758 | 237.5780 USD |
| Sale | 3,986 | 237.9057 USD |
| Sale | 7,766 | 237.6425 USD |
| Sale | 7,998 | 237.1499 USD |
| Sale | 9,107 | 237.3484 USD |
| Sale | 9,868 | 237.7548 USD |
| Sale | 10,581 | 237.4155 USD |
| Sale | 10,948 | 237.6194 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 12 Apr 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
| Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210412005810/en/
Copyright Business Wire 2021